Heran Tech, a major player in Accelerator-based Boron Neutron Capture Therapy (AB-BNCT), held a groundbreaking ceremony for its new corporate headquarters in the Hsinchu Biomedical Science Park on June 1. The facility is expected to be completed by 2028 and will serve as a global hub for operations, R&D, and high-end pharmaceutical manufacturing. Founded with investment from the Hermes-Epitek Group, Heran Tech is Taiwan's first company focused on AB-BNCT systems. Due to rapid growth and talent expansion, the company outgrew its current space. The new headquarters will feature R&D labs and international-standard manufacturing facilities. Additionally, Well-Being Biotech, a leader in in-vitro diagnostics, opened its new headquarters, integrating testing services, health checkups, and medical information platforms to enhance operational efficiency.

FACT BOX

  • Source: CNA (Central News Agency)
  • Category: business